FDA.reportPublic FDA data

vonicog alfa 1 UNT Injection

RxCUI
1812593
RxNorm name
vonicog alfa 1 UNT Injection
Display name
vonicog alfa 1 UNT Injection
Full name
vonicog alfa 1 UNT Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125577Vonvendivon Willebrand factor (Recombinant)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
53b6d198-6175-4a26-8606-dc0d2a0f12d6vonicog alfa 1 UNT Injection [PSN] · vonicog alfa 1 UNT Injection [SCD]220These highlights do not include all the information needed to use VONVENDI ® safely and effectively. See full prescribing information for VONVENDI. VONVENDI [von Willebrand factor (recombinant)] lyophilized powder for solution, for intravenous injection Initial U.S. Approval: 201520251024